A detailed history of Hsbc Holdings PLC transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Hsbc Holdings PLC holds 125,365 shares of TLSA stock, worth $114,082. This represents 0.0% of its overall portfolio holdings.

Number of Shares
125,365
Previous 164,226 23.66%
Holding current value
$114,082
Previous $73,000 57.53%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$0.43 - $1.01 $16,710 - $39,249
-38,861 Reduced 23.66%
125,365 $115,000
Q4 2023

Feb 12, 2024

SELL
$0.55 - $0.85 $11,000 - $17,000
-20,000 Reduced 10.86%
164,226 $91,000
Q3 2023

Nov 13, 2023

SELL
$0.6 - $0.82 $72,624 - $99,253
-121,041 Reduced 39.65%
184,226 $121,000
Q2 2022

Aug 11, 2022

SELL
$0.66 - $1.06 $92,589 - $148,704
-140,287 Reduced 31.49%
305,267 $227,000
Q1 2022

May 16, 2022

SELL
$0.62 - $1.25 $37,200 - $75,000
-60,000 Reduced 11.87%
445,554 $468,000
Q4 2021

Feb 11, 2022

BUY
$0.89 - $1.66 $449,943 - $839,219
505,554 New
505,554 $485,000

Others Institutions Holding TLSA

About Tiziana Life Sciences Ltd


  • Ticker TLSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,273,000
  • Market Cap $93.1M
  • Description
  • Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...
More about TLSA
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.